Latest Articles

WuXi ATU Sponsors the Believe Ball, Hosts Tom Whitehead, and Launches a Book Club Starting with Praying for Emily: The Faith, Science, and Miracles That Saved Our Daughter

WuXi Advanced Therapies had the immense honor of sponsoring this year’s Emily Whitehead Foundation Believe Ball, held on September 27th in Philadelphia. It was a night to remember, filled with hope, inspiration, and community. The event brought together industry leaders, supporters, and patient warriors who have fought and continue to fight for a future with better access to life-saving therapies

All articles

WuXi ATU in Action: Conquering Mountains and 5Ks for Kinder Care and Melanoma Research

XOFLX™ Technology Undergoes Peer Review: Published in Molecular Therapy Clinical Methods & Development

XOFLX publication in Molecular Therapy Clinical Methods and Development

Pioneering Scalable Solutions in AAV Manufacturing and Testing for Gene Therapy

wuxi advanced therapies tessa aav scalable production

Five Best Practices to Adapt and Improve Quality Control Programs for CGTs

WuXi Advanced Therapies_Analytical Testing_QBD

6 Key Questions to Cover When Selecting Your Cell Banking Manufacturing Partner

WuXi Advanced Therapies 6 Considerations Cell Banking

WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance’s AMTAGVI™ (lifileucel) for Advanced Melanoma

Comercial Manufacturing site in Philadelphia

WuXi Advanced Therapies Supports First Investigational CD19 CAR-T Therapy Approved by China’s NMPA

Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201

WuXi Advanced Therapies Cabaletta CABA-201

WuXi ATU and T-MAXIMUM Announce Strategic Partnership of Cooperation for MT-027 UCAR-T

Resources

Gain access to white papers, posters, videos, case studies, brochures and more.

  1. XOFLX™ stable cell lines: a flexible platform for lentiviral vector production

    Poster

  2. Promoter Screening to Enhance Scalable Recombinant AAV Manufacture from TESSA®

    Poster

  3. Infectivity Measurements of AAV Vectors Using TESSA®-Rep Enabled AAV Titration (TREAT)

    Poster
Access All Resources
Ameba Creative StudioAmeba Creative Studio